Core Points - Fitzroy Minerals Inc. plans to complete a non-brokered listed issuer financing exemption (LIFE) private placement, aiming to raise up to $12 million at a price of $0.30 per share, with a minimum offering amount of $8 million [1][2] - The company will also conduct a concurrent non-brokered private placement of up to $1 million through the issuance of up to 3,333,333 shares at the same price [3] - Proceeds from the private placements will be allocated for exploration activities, property commitments, general administrative costs, and working capital [4] Regulatory and Offering Details - The LIFE Offering is conducted under National Instrument 45-106 and will not have a hold period under Canadian securities laws [2] - Securities from the concurrent offering will be subject to a statutory hold period of four months and one day [3] - The closing of the private placements is expected around July 5, 2025, pending TSXV approval [5] Insider Participation - Insiders of the company are expected to participate in the concurrent offering, which may be considered a related party transaction but will be exempt from certain formal requirements [6] Company Overview - Fitzroy Minerals focuses on exploring and developing mineral assets in the Americas, with projects including Buen Retiro and Caballos in Chile, Taquetren in Argentina, and Cariboo in Canada [9]

Core Viewpoint - Silver North Resources Ltd. is conducting a non-brokered private placement to raise up to $2,100,000 through the sale of charity flow-through units at a price of $0.21 per unit, aimed at funding exploration activities on its mineral properties in the Yukon Territory [1][2]. Group 1: Offering Details - The Offering consists of charity flow-through units (CFT Units), each comprising one common share and one-half of a common share purchase warrant, with the warrant allowing the purchase of one common share at an exercise price of $0.35 for 48 months [1]. - The gross proceeds from the sale of CFT Units will be used to incur eligible Canadian exploration expenses related to the Company's projects in the Yukon, with a commitment to renounce these expenditures to subscribers by December 31, 2025 [3]. Group 2: Exploration Plans - Proceeds from the financing will be allocated to exploration programs on the Haldane and GDR projects, including a prospecting and mapping program on the Veronica claim block of the GDR Project, which is adjacent to the Tim Property [8]. - At Haldane, a diamond drilling program consisting of 10 holes (2,500 meters) will target the expansion of silver-lead-zinc mineralization at the Main Fault target, with previous drilling returning significant grades of silver and other minerals [9]. Group 3: Regulatory Compliance - The Offering will comply with the policies of the TSX Venture Exchange and is subject to necessary regulatory approvals [4]. - The Offered Securities will be available for sale to purchasers in Canada and other qualifying jurisdictions without a hold period due to the Listed Issuer Financing Exemption [5].

Company Overview - MAX Power Mining Corp. is focused on the Natural Hydrogen sector and has established a significant land position of approximately 1.3 million acres (521,000 hectares) for exploration [9] - The company is also involved in critical minerals exploration, highlighted by a recent diamond drilling discovery at the Willcox Playa Lithium Project in southeast Arizona [9] Leadership Addition - Former Minister of SaskPower, Mr. Rob Norris, has joined MAX Power's Board of Directors, bringing extensive experience in government and business development [1][2] - Mr. Norris has a history of launching significant initiatives in Saskatchewan, including the Boundary Dam CCS Project and the Saskatchewan International Minerals Innovation Institute [2] Strategic Focus - Mr. Norris emphasized the unique opportunities in the Natural Hydrogen space and the company's commitment to economic reconciliation through partnerships with Indigenous-owned businesses [5] - The CEO of MAX Power, Mr. Mansoor Jan, highlighted the need for a diverse skill set on the Board to address the growing understanding of Natural Hydrogen formation in Saskatchewan [7]

Core Insights - Lexaria Bioscience Corp. has received 2 new international patents, increasing its total patent portfolio to 50 [1][2] - The new patents include one for treating epilepsy and another for sublingual delivery of nicotine, enhancing Lexaria's intellectual property protection [2][3] - The epilepsy drug market was valued at US$9.5 billion in 2023 and is projected to exceed US$15 billion by 2032, indicating significant growth potential [4] - The global retail oral nicotine market was valued at US$5.5 billion in 2023 and is expected to grow at a rate of 26% per year until at least 2030 [5] Company Developments - Lexaria's new patent for epilepsy treatment broadens its intellectual property protection outside the USA, where it already holds 6 existing patents [2] - The new patent for sublingual delivery of nicotine adds to existing patents in the USA and Canada, further solidifying Lexaria's position in the nicotine market [3] - The new patents are seen as a strategic move to enhance commercial opportunities within the pharmaceutical industry and to build long-term value for shareholders [2] Market Context - Approximately 50 million people in the US are affected by epilepsy, highlighting a substantial patient population for potential treatments [4] - The nicotine pouch market, where Lexaria's DehydraTECH™ technology has shown absorption benefits, is expected to reach US$25.4 billion in revenue by 2030 [5] - Lexaria's DehydraTECH™ technology improves the delivery of active pharmaceutical ingredients, demonstrating increased bio-absorption and effectiveness across the blood-brain barrier [6]

Re-2Ox hydrometallurgical system addresses arsenic barrier to battery metals recovery Coquitlam, BC – TheNewswire - June 23, 2025 - Nord Precious Metals Mining Inc. (TSX-V: NTH | OTCQB: CCWOF | FRANKFURT: 4T9B) announced today it has secured $200,000 in funding from the Mining Innovation Commercialization Accelerator (MICA) Network to advance its Re-2Ox technology from Technology Readiness Level 6 to TRL 7, positioning the system for commercial deployment and licensing opportunities. The funding, part of MI ...

Core Viewpoint - Femto Technologies Inc. is set to be delisted from Nasdaq, transitioning to OTC trading under the symbol "FMTOF" starting June 23, 2025 [1] Company Overview - Femto Technologies Inc. is a pioneering Femtech company focused on wellness technology, emphasizing AI-driven solutions to enhance well-being [3] - The company was previously known as BYND Cannasoft Enterprises Inc. [1] Delisting and Future Plans - The Nasdaq Hearings Panel has determined to delist the company's common shares, but the company is exploring options including an appeal and potential listings on Canadian or European exchanges [2] - Despite the delisting, the company asserts that its stable financial condition will not affect its operations or business plan execution [2] Product Highlight - Sensera is a feminine wellness device developed by Femto Technologies, utilizing proprietary Smart Release System (SRS) technology, including machine learning and AI, to enhance feminine wellness [4]

Core Viewpoint - Quantum Critical Metals Corp. plans to raise between $2,000,000 to $3,000,000 through a non-brokered private placement financing by selling 20,000,000 to 30,000,000 units at a price of $0.10 per unit, with each unit consisting of one common share and one warrant [1][2]. Group 1 - The net proceeds from the Offering will be used for continued exploration activities on the Company's properties in British Columbia and Quebec, as well as for general corporate purposes [2]. - The Offering is expected to close on or about June 30, 2025, and may be completed in one or more tranches, subject to TSX Venture Exchange approval and customary conditions for private placements [3]. - All securities issued will be subject to a statutory hold period of four months and one day from the date of issue [3]. Group 2 - The Company may pay a finder's fee to certain individuals who introduce purchasers to the Offering, in accordance with TSXV policies [4]. - Certain insiders are expected to participate in the Offering, which qualifies as a "related party transaction" under Multilateral Instrument 61-101, but is exempt from formal valuation and minority shareholder approval requirements [5]. Group 3 - Quantum Critical Metals Corp. is a Canadian mineral exploration company focused on advancing critical metals projects, with a portfolio that includes various projects in Quebec and British Columbia [8].

Core Points - Silver Crown Royalties Inc. has signed a Letter of Intent with Kuya Silver Corp. to acquire a 4.5% royalty on silver produced from the Bethania Silver Mine in Peru [1][3] - The Bethania Silver Mine resumed production in May 2024 and was previously operational until 2016 [2] - The acquisition will involve a payment of US$3,000,000 in cash and US$2,000,000 in Silver Crown units, with each unit priced at C$6.50 [3] - Silver Crown will receive varying amounts of silver over time, starting with 4,500 ounces per quarter for the first year, increasing to 12,375 ounces per quarter for the subsequent years, before reducing to 1% royalty after 475,000 ounces [4] - The partnership is expected to significantly increase Silver Crown's annual silver revenue from 78,000 to over 128,000 ounces [5] Company Overview - Silver Crown Royalties Inc. is a publicly traded silver royalty company with four silver royalties, three of which are revenue-generating [5] - The company's business model provides investors with exposure to precious metals while minimizing the impact of cost inflation associated with production [5]

Company Name Change - The company has received TSX approval to change its name from "Green Battery Minerals Inc." to "First Canadian Graphite Inc." [1] - The common shares will commence trading under the new name and symbol FCI on June 20, 2025 [2]. Share Structure - There is no consolidation of the company's share capital associated with the name change, meaning shareholders do not need to exchange existing share certificates [3]. - The name change does not affect the company's share structure or the rights of shareholders, and no further action is required by existing shareholders [3].

Core Viewpoint - BetterLife Pharma Inc. has received an ISSUE NOTIFICATION from the US Patent and Trademark Office for its BETR-001 composition of matter patent, which provides strong intellectual property protection until at least 2042 [1][4]. Patent and Intellectual Property - The patent covers various claims related to crystalline forms of BETR-001, its formulations, and isomers [3]. - The composition of matter patent is considered the strongest level of intellectual property coverage for a compound [4]. Product Development - BETR-001 is a non-hallucinogenic neuroplastogen aimed at treating psychiatric and neurological disorders, including depression, anxiety, PTSD, traumatic brain injury, migraines, and neuropathic pain [4][8]. - The company has completed most IND-enabling studies and plans to file for IND and start human trials in H1 2026 [5]. Financial and Shareholder Information - BetterLife has issued a total of 6,473,712 common shares and the same number of share purchase warrants, related to convertible debentures and accrued interest totaling $647,371 [6]. - The share purchase warrants are exercisable at an exercise price of $0.10 per warrant and have varying expiration dates [6]. Company Overview - BetterLife Pharma is focused on developing and commercializing compounds for neuro-psychiatric and neurological disorders, specifically BETR-001 and BETR-002 [7]. - BETR-002 is based on honokiol and is also in preclinical studies, targeting anxiety-related disorders [9]. - The company is exploring strategic alternatives for further development of a drug candidate for viral infections [10].